BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250320T190000
DTEND;TZID=Africa/Nairobi:20250320T203000
DTSTAMP:20260424T040811
CREATED:20250611T192311Z
LAST-MODIFIED:20250622T142307Z
UID:38878-1742497200-1742502600@kesho-kenya.org
SUMMARY:Metastatic Colorectal Cancer
DESCRIPTION:Moderator: Dr Alex Muturi \nSpeakers & Topics: \n\nProf Olusegun Alatise: Surgical & Gastroenterology Perspectives in mCRC Management\nDr Andrew Odhiambo: First‑Line Therapy in mCRC – With or Without?\n\nGlobal and African Burden of CRC \n– CRC is the third most diagnosed cancer globally with an increasing burden in LMICs.\n– African patients show distinct molecular and clinical features\, including poor survival outcomes. \nPrinciples of Metastatic CRC Management \n– Multidisciplinary approach is essential; cure remains possible in select patients.\n– Surgery for metastasis should be guided by tumor biology\, technical feasibility\, and patient fitness.\n– Synchronous vs metachronous disease influences treatment sequencing. \nImaging and Surgical Considerations \n– Triphasic CT\, MRI with contrast\, and PET scans are standard.\n– Resectability is based on liver function and margin clearance\, not number/size of lesions. \nSurgical and Interventional Therapies \n– Options: surgical resection\, ablation\, HAIP chemotherapy\, two-stage hepatectomy\, ALPPS\, SIRT.\n– Preoperative chemotherapy helps with tumor downsizing and biology assessment but may impair liver function. \nGenetic and Prognostic Scoring \n– CRS\, GAME\, MRS\, and MSI/BRAF/TP53 profiles aid in stratifying patients.\n– Even high-risk patients can achieve long-term survival with careful selection. \nNewer Modalities \n– Thermal ablation is effective for small (<3cm) liver lesions.\n– Liver transplant is under investigation for select liver-only\, unresectable CRC. \nPeritoneal Carcinomatosis \n– Cytoreductive surgery + HIPEC has survival benefits in low PCI scores.\n– PRODIGE 7\, COLOPEC\, and PROPHYLOCHIP trials show limited benefit of prophylactic HIPEC \nConclusion \n– Metastatic CRC is treatable; coordinated\, case-specific care improves survival.\n– Early detection and healthcare system strengthening in Africa are vital.
URL:https://kesho-kenya.org/event/metastatic-colorectal-cancer-3/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/Metastatic-Colorectal-Cancer-e1749669731932.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250313T190000
DTEND;TZID=Africa/Nairobi:20250314T203000
DTSTAMP:20260424T040811
CREATED:20251222T171550Z
LAST-MODIFIED:20251223T152912Z
UID:40767-1741892400-1741984200@kesho-kenya.org
SUMMARY:WoCa Summit EA
DESCRIPTION:
URL:https://kesho-kenya.org/event/woca-summit-ea/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250313T190000
DTEND;TZID=Africa/Nairobi:20250313T203000
DTSTAMP:20260424T040811
CREATED:20250611T192853Z
LAST-MODIFIED:20250622T142307Z
UID:38882-1741892400-1741897800@kesho-kenya.org
SUMMARY:Women in Oncology
DESCRIPTION:International Women’s Day: Women in Oncology \nModerator: Ms Benda Kithaka \nSpeakers & Topics: \n\nDr Catherine Nyongesa: Women in Leadership\nDr Khadija Warfa: Challenges Faced by Women in Oncology\nDr Gladwell Kiarie: Women in Oncology – How to Step Up the Game!\nProf Nazik Hammad: Harnessing Solidarity Between African Women in Oncology\n\nDr. Warfa discussed the multifaceted challenges faced by female oncologists in Africa\, including work-life imbalance\, gender-based microaggressions\, and structural sexism. She emphasized how family responsibilities\, limited mentorship\, and hierarchical work environments hinder progress. Solutions include flexible work arrangements\, inclusive leadership\, bias training\, and equitable opportunities for advancement. She also highlighted the importance of accurate gender representation in medical discourse and the superior clinical outcomes observed among female physicians. \nDr. Nyongesa focused on leadership development for women in oncology\, identifying critical attributes such as emotional intelligence\, vision\, resilience\, and effective communication. She encouraged mentorship\, strategic positioning\, and self-awareness. The presentation promoted intentional leadership development and emphasized that empowered women are key to empowering entire communities. \nDr. Kiarie highlighted systemic gender disparities in oncology\, such as underrepresentation in leadership\, editorial boards\, and conferences. She emphasized key challenges including lack of mentorship\, pay gaps\, burnout\, and societal biases. Proposed solutions included implementing mentorship and sponsorship programs\, advocating for inclusive policies\, prioritizing self-care\, and establishing supportive networks. She stressed the importance of visibility\, advocacy\, and proactive self-promotion for career progression
URL:https://kesho-kenya.org/event/women-in-oncology/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2025/06/Women-in-Oncology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250306T190000
DTEND;TZID=Africa/Nairobi:20250306T203000
DTSTAMP:20260424T040811
CREATED:20250611T193255Z
LAST-MODIFIED:20250622T142307Z
UID:38887-1741287600-1741293000@kesho-kenya.org
SUMMARY:Updates in Myeloma Management
DESCRIPTION:Moderator: Dr Angela Mcligieyo \nSpeakers & Topics: \n\nDr M. B. Agarwal: Front‑line Therapy Trends\nDr Rohini Radia: Transplant‑Eligible vs Ineligible Patients\nDr M. D. Maina: Evidence‑Based Maintenance\nDr Boniface Githae: Contemporary Relapse Strategies\n\nDr. Maina addressed Smoldering Multiple Myeloma (SMM)\, emphasizing risk stratification to predict progression to active myeloma. The 2/20/20 IMWG model (based on FLC ratio and bone marrow plasma cell %)\, and the Spanish model using immunoparesis and plasma cell phenotyping\, were presented. Patients with ≥2 risk factors have a 50% chance of progression within 2 years. Ongoing efforts to integrate clinical and genomic risk markers aim to guide early therapeutic interventions. \nDr. Radia emphasized that autologous stem cell transplant (ASCT) remains the standard of care for transplant-eligible patients after induction chemotherapy. Key findings from major trials (IFM2009\, EMN02/H095) showed that ASCT improves progression-free survival (PFS) but does not significantly impact overall survival (OS). Post-ASCT maintenance therapy with lenalidomide improves PFS across all cytogenetic risk groups. CAR-T cell therapy and bispecific antibodies like Teclistamab and Elranatamab show promise in relapsed/refractory multiple myeloma (RRMM)\, offering new options with high response rates\, albeit with logistical and toxicity concerns. Kenyan real-world data shows promising survival outcomes with ASCT. \nDr. Githaiga presented practical approaches to diagnosis\, transplant eligibility\, and treatment selection. Diagnostic workups include comprehensive labs and bone marrow studies. For transplant-eligible patients\, quadruplet regimens like Dara-VRd followed by ASCT and lenalidomide maintenance are preferred. In high-risk cases\, bortezomib-based maintenance is advised. In non-transplant candidates\, extended triplet regimens followed by maintenance were recommended. He also highlighted Kenyan drug cost considerations and the importance of supportive care with antivirals\, antibiotics\, and bone-targeting agents.
URL:https://kesho-kenya.org/event/updates-in-myeloma-management/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/Updates-in-Myeloma-Management-e1749726883405.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250305T190000
DTEND;TZID=Africa/Nairobi:20250305T203000
DTSTAMP:20260424T040811
CREATED:20251222T171137Z
LAST-MODIFIED:20251223T152927Z
UID:40763-1741201200-1741206600@kesho-kenya.org
SUMMARY:Kidney Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/kidney-cancer-2/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250227T190000
DTEND;TZID=Africa/Nairobi:20250227T203000
DTSTAMP:20260424T040811
CREATED:20250611T193814Z
LAST-MODIFIED:20250622T142307Z
UID:38891-1740682800-1740688200@kesho-kenya.org
SUMMARY:AML: A Local Perspective
DESCRIPTION:Moderator: Prof Abinya \nSpeakers & Topics: \n\nDr Anne Mwirigi: Local Experience at a Tertiary Hospital\nDr Rohini Radia: The Role of Cytogenetics & Molecular Markers\nDr Peter Oyiro: Genomic Classification & Medical Oncology Pathways\nDr Beatrice Jepngetich: Panelist Discussion\nDr Mercy Gatua: Panelist Discussion\n\n Summary \nAML is genetically heterogeneous\, with most patients having multiple driver mutations.\n– WHO 2022 classification emphasizes genetic abnormalities over morphology or blast count.\n– Defining cytogenetic lesions like inv(16) or t(8;21) now suffice for diagnosis even with <20% blasts. \nDiagnostic Work-Up \n– FBC and peripheral blood smear\n– Bone marrow aspirate: morphology\, flow cytometry\, LAIP for MRD\n– Cytogenetics: Karyotyping and FISH\n– Next-Generation Sequencing (NGS): TP53\, NPM1\, etc.\n– Bone marrow trephine with immunocytochemistry. \nClinical Implications \n– Risk stratification through cytogenetics + molecular testing informs prognosis and treatment plan.\n– Favorable-risk patients may receive chemotherapy; adverse-risk patients considered for early allogeneic transplant.\n– MRD monitoring increasingly guides transplant decisions. \nTakeaways \n– AML is curable in a subset with intensive chemo + risk-adapted approach.\n– Precision oncology depends on accessible molecular diagnostics.\n– LMICs face challenges integrating NGS-based stratification.\n– Hypomethylating agents + Venetoclax offer promise in select patient groups.
URL:https://kesho-kenya.org/event/aml-a-local-perspective/
LOCATION:Aga Khan University\, Nairobi
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/A-Local-Perspective-e1749671173338.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250220T190000
DTEND;TZID=Africa/Nairobi:20250220T193000
DTSTAMP:20260424T040811
CREATED:20250217T194237Z
LAST-MODIFIED:20250622T142307Z
UID:38895-1740078000-1740079800@kesho-kenya.org
SUMMARY:International Childhood Cancer Day
DESCRIPTION:Moderator: Dr Alice Gichemi \nSpeaker & Topic: \nDr Terry Vik: Flow Cytometry for Rapid Diagnosis of Lymphoid Malignancies in Children & Teenagers \nGlobal Context \n– Childhood cancer cure rates: 80% in high-income countries\, ~30% in LMICs.\n– Barriers: delayed diagnosis\, treatment abandonment\, limited diagnostic access.\n– WHO/SIOP target: Double survival and save 1 million children by 2030. \n Leukemia Diagnosis in Kenya \n– Common signs: Pallor\, Pyrexia\, Purpura\, Pain (bony).\n– First-line tests: CBC and peripheral smear.\n– Many children present with Hgb < 7.0 — indicates late presentation. \nRole of Flow Cytometry \n– Globally standard for classifying ALL/AML.\n– In Kenya\, it’s reducing time-to-treatment\, especially in Burkitt Lymphoma (from 13.6 to 10.5 days).\n– Used on both bone marrow and peripheral blood samples for early diagnosis. \n Clinical Pilot Highlights \n– MTRH pilot expanding to 100 patients in 2026.\n– Focus: Feasibility of flow cytometry in peripheral blood diagnostics.\n– Goal: Develop scalable and SHIF/NHIF-coverable diagnostic methods. \nKey Clinical Takeaways \n– Recognize early signs of leukemia using the 4 P’s.\n– Flow cytometry is feasible and impactful in Kenya.\n– Early diagnosis can save lives — integration into local protocols is critical.
URL:https://kesho-kenya.org/event/international-childhood-cancer-day/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/International-Childhood-Cancer-Day-e1749670857260.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250219T190000
DTEND;TZID=Africa/Nairobi:20250219T203000
DTSTAMP:20260424T040811
CREATED:20251222T170110Z
LAST-MODIFIED:20251223T152934Z
UID:40761-1739991600-1739997000@kesho-kenya.org
SUMMARY:Gallbladder & Bile Duct Cancer  Awareness
DESCRIPTION:
URL:https://kesho-kenya.org/event/gallbladder-bile-duct-cancer-awareness/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250206T190000
DTEND;TZID=Africa/Nairobi:20250206T203000
DTSTAMP:20260424T040811
CREATED:20250203T194848Z
LAST-MODIFIED:20250623T131746Z
UID:38898-1738868400-1738873800@kesho-kenya.org
SUMMARY:United for Cancer Prevention
DESCRIPTION:United for Cancer Prevention – People‑Centered Approaches in Healthcare\n\nModerator: Dr Douglas Nyandika\n\nSpeakers & Topics:\n\n 	Carol Wakesa: Community‑Led Prevention Strategies\n 	Dr Joan‑Paula Boit: Risk‑Reduction in Gynaecologic Cancers\n 	Dr Jerome Katamba: Behavioural Science & Cancer Prevention\n 	Dr Francis Makokha: The Socio‑Economic Determinants of Prevention Uptake\n 	Mr David Makumi: Building Survivor‑Led Advocacy Networks
URL:https://kesho-kenya.org/event/united-for-cancer-prevention/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/United-for-Cancer-Prevention-e1749671294368.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250205T190000
DTEND;TZID=Africa/Nairobi:20250205T203000
DTSTAMP:20260424T040811
CREATED:20251222T165950Z
LAST-MODIFIED:20251223T153047Z
UID:40757-1738782000-1738787400@kesho-kenya.org
SUMMARY:World Cancer Day   Building a Resilient Oncology  Workforce: Addressing Capacity  Gaps in Cancer Management in  Kenya
DESCRIPTION:
URL:https://kesho-kenya.org/event/world-cancer-day-building-a-resilient-oncology-workforce-addressing-capacity-gaps-in-cancer-management-in-kenya/
CATEGORIES:CME 2026,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250123T190000
DTEND;TZID=Africa/Nairobi:20250123T203000
DTSTAMP:20260424T040811
CREATED:20250611T183601Z
LAST-MODIFIED:20250622T142307Z
UID:38855-1737658800-1737664200@kesho-kenya.org
SUMMARY:Cervical Cancer Care
DESCRIPTION:Advanced Ovarian Cancer \nModerator: Prof Rose J. Kosgei \nSpeakers & Topics: \n\nProf Omenge Orang’o: Management of Epithelial Ovarian Cancer\nDr Peter Oyiro: PARP Inhibitors in Ovarian Cancer\nDr Charles Muteshi: Fertility Preservation in Ovarian Cancer\n\nEpidemiology and Diagnosis (Prof. Omenge Oran’go) \n– Ovarian cancer remains a significant cause of cancer mortality among women due to its asymptomatic nature in early stages.\n– Kenya sees many cases diagnosed at advanced stages (III/IV)\, primarily due to non-specific symptoms and lack of screening.\n– Important to understand pelvic anatomy and tumor spread patterns for accurate diagnosis and surgical planning. \nFertility Preservation in Ovarian Cancer (Dr. Charles Muteshi) \n– Fertility-sparing surgery should be considered in selected early-stage epithelial ovarian cancers (Stage I).\n– Discussion on embryo/oocyte cryopreservation for patients undergoing gonadotoxic treatment.\n– Emphasized need for multidisciplinary counseling and prompt fertility consultations to ensure oncologic safety and reproductive potential. \nRole of PARP Inhibitors (Dr. Peter Oyiro) \n– PARP inhibitors like Olaparib offer significant benefits in BRCA-mutated and homologous recombination-deficient (HRD) ovarian cancers.\n– SOLO-1 and SOLO-2 studies demonstrated prolonged progression-free survival and delayed recurrence in both frontline and maintenance settings.\n– 7-year follow-up data show sustained benefit\, with over 48% progression-free survival in Olaparib arms.\n– Low incidence of serious adverse events\, with anemia\, fatigue\, and nausea as the most common.\n– Highlighted integration into Kenya Cancer Treatment Guidelines and importance of HRD testing.
URL:https://kesho-kenya.org/event/cervical-cancer-care/
CATEGORIES:CME 2025,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2025/06/Cervical-Cancer-scaled-e1749667096838.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241121
DTEND;VALUE=DATE:20241124
DTSTAMP:20260424T040811
CREATED:20250405T100852Z
LAST-MODIFIED:20250617T190404Z
UID:10179-1732147200-1732406399@kesho-kenya.org
SUMMARY:The 8th Kenya International Cancer Conference
DESCRIPTION:[vc_row][vc_column]    \n    	\n                	Theme: Advancing Cancer Care in Africa in a Rapidly Changing World                \n        \n    \n    [/vc_column][/vc_row][vc_row][vc_column][vc_tta_accordion active_section=”1″][vc_tta_section title=”Executive Summary” tab_id=”1750171339446-13ebbf68-b6b3″][vc_column_text css=””]8th Kenya International Cancer Conference (KICC) 2024: Executive Summary\nDates & Venue: November 21–23\, 2024 | Grand Royal Swiss Hotel\, Kisumu\, Kenya\nTheme: “Advancing Cancer Care in Africa in a Rapidly Changing World” \nConference Snapshot \nAttendees: 574 delegates from Kenya\, Israel\, Rwanda\, South Africa\, Italy\, Canada\, Tanzania\, USA\, UK\, Germany\, Ethiopia\, Uganda. \nAbstracts: 168 submissions with 124 poster presentations and a total of 128 speakers. \nPreconference Events: \n\nOutreach Screening & Wellness Fair (Nov 19)\nRadiation Oncology Contouring & Planning Workshop (Nov 20)\nFaculty Development Workshop (Nov 20)\nGrant Writing Workshop (Nov 20)\n\nKey Topic Areas \n1. Oncology & Allied Specialties \nUpdates on multidisciplinary teamwork\, oncology nursing\, pharmacy\, and allied health services in comprehensive cancer care. \n2. Reciprocal Innovation \nShowcasing African-born technological and clinical approaches that can be scaled or adapted globally. \n3. Impact of AI & Digital Health \nSpotlight on telemedicine\, data analytics\, and emerging digital platforms transforming early detection and patient tracking. \n4. Improving Access to Cancer Care \nStrategies for reducing financial\, geographic\, and infrastructural barriers—highlighting national policies\, insurance models\, and cross-sector collaboration. \n5. Palliative & Supportive Care\, Survivorship \nApproaches to pain management\, end-of-life care\, psychosocial support\, and patient navigation for survivors and their families. \n6. Community Engagement & Prevention \nGrassroots outreach for cancer screening and education\, emphasizing local leadership in raising awareness and encouraging early interventions. \n7. Cancer Care in Times of Crisis & Climate Change \nResilience planning for cancer services during pandemics\, natural disasters\, and environmental shifts. \nAbstract Summaries \n1. Novel Diagnostics & Genomic Insights \nStudies on molecular profiling\, targeted therapies\, and liquid biopsies to improve personalized care. \n2. Therapeutic Advancements \nResearch on immunotherapies\, hypofractionated radiotherapy\, and innovative drug regimens showing promise in improving survival rates. \n3. Health Systems & Policy \nPresentations on public-private partnerships\, financing models\, and community-based strategies that strengthen cancer prevention and control. \n4. Clinical Trials & Capacity Building \nInsights into collaborative research networks\, training programs for oncology professionals\, and resource-sharing across institutions. \nOutreach & Community Impact \nOn November 19\, KESHO and 23 partner organizations led a free Outreach Screening & Wellness Fair at Mamboleo Junction in Kisumu. This initiative provided critical onsite cancer screenings and health education for residents. \nParticipation & Impact: Local leadership—including the Governor of Kisumu\, CEC Health—joined the event\, amplifying community trust and media attention. \nScreening Highlights: \n\n134 samples collected and tested\n43 positive outcomes requiring further evaluation\n82 negative outcomes\n9 tests repeated or invalid\nOverall\, 125 individuals received confirmed results on the day\n\nCommunity Education: In addition to screenings\, attendees received guidance on prevention measures\, healthy lifestyle habits\, and the importance of timely cancer checkups. \nConclusion \nKICC 2024 demonstrated rising momentum for collaborative\, data-driven\, and patient-centered oncology solutions in Africa. From policy debates to clinical workshops\, the event galvanized professionals across disciplines to accelerate access\, innovation\, and research in cancer care—ultimately driving improved outcomes for communities across the continent. \nWe look forward to continued partnerships and ground-breaking progress leading up to KICC 2026.[/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row][vc_row][vc_column][vc_toggle title=”Exhibitors” css=””]	\n		\n			\n\n				\n					\n				\n\n\n	\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n				\n	\n\n				\n				\n			\n		\n	\n		[/vc_toggle][/vc_column][/vc_row][vc_row][vc_column][vc_toggle title=”Outreach Partners” css=””]	\n		\n			\n\n				\n					\n				\n\n\n	\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n				\n	\n\n				\n				\n			\n		\n	\n		[/vc_toggle][/vc_column][/vc_row][vc_row][vc_column][vc_toggle title=”Sponsors” css=””]	\n		\n			\n\n				\n					\n				\n\n\n	\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n		\n			\n				\n\n					\n					\n					\n										\n					\n										\n				\n			\n\n				\n	\n\n				\n				\n			\n		\n	\n		[/vc_toggle][vc_toggle title=”Attendance” css=””][/vc_toggle][vc_tta_accordion active_section=””][vc_tta_section title=”Program” tab_id=”1750173149878-8e55e2c9-68cd”][vc_column_text css=””]\n\n\n    Download    PDF Loading...\n    \n        \n    \n    \n\n[/vc_column_text][/vc_tta_section][vc_tta_section title=”Resources” tab_id=”1750185088680-65ad05b2-afcd”][vc_column_text css=””]\n\n\n    Download    PDF Loading...\n    \n        \n    \n    \n\n[/vc_column_text][/vc_tta_section][vc_tta_section title=”Media Coverage” tab_id=”1750184867395-c51391fa-7ba8″][vc_column_text css=””]\n\n\n    Download    PDF Loading...\n    \n        \n    \n    \n\n[/vc_column_text][/vc_tta_section][vc_tta_section title=”Photos” tab_id=”1750172885997-f40c2543-a705″][vc_column_text css=””]Outreach \nConference[/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/2024-kenya-international-cancer-conference/
LOCATION:Grand Royal Swiss Hotel Kisumu\, Kenya
CATEGORIES:Conferences,Webinar Recording Available
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241120T090000
DTEND;TZID=Africa/Nairobi:20241120T160000
DTSTAMP:20260424T040811
CREATED:20240423T133333Z
LAST-MODIFIED:20250622T142510Z
UID:9634-1732093200-1732118400@kesho-kenya.org
SUMMARY:Grant Writing Workshop: KESHO
DESCRIPTION:[vc_row][vc_column][vc_btn title=”REGISTER” color=”danger” link=”url:https%3A%2F%2Fforms.gle%2FoRL4wT3yvhcrjqaN9″][vc_tta_accordion][vc_tta_section title=”Program” tab_id=”“][vc_column_text]    	\n        View Programme         \n        [/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/grant-writing-workshop-kesho/
LOCATION:Grand Royal Swiss Hotel\, Kisumu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241120T080000
DTEND;TZID=Africa/Nairobi:20241120T170000
DTSTAMP:20260424T040811
CREATED:20240423T133943Z
LAST-MODIFIED:20250622T142510Z
UID:9636-1732089600-1732122000@kesho-kenya.org
SUMMARY:Faculty Development Workshop–KESHO-AORTIC
DESCRIPTION:[vc_row][vc_column][vc_btn title=”REGISTER” color=”danger” link=”url:https%3A%2F%2Fforms.gle%2FPtZJ24i7EZjb99Ug6″][vc_tta_accordion][vc_tta_section title=”Program” tab_id=”1713883753274-199596d0-b3a5″][vc_column_text]    	\n        View Programme         \n        [/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/faculty-development-workshop-kesho-aortic/
LOCATION:Grand Royal Swiss Hotel\, Kisumu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241120T080000
DTEND;TZID=Africa/Nairobi:20241120T170000
DTSTAMP:20260424T040811
CREATED:20240423T134228Z
LAST-MODIFIED:20250622T142510Z
UID:9638-1732089600-1732122000@kesho-kenya.org
SUMMARY:Radiation Oncology Contouring and Planning  Pre-Conference Workshop
DESCRIPTION:[vc_row][vc_column][vc_btn title=”Register” color=”danger” link=”url:https%3A%2F%2Fforms.gle%2FHkkCbYAZc6ZtXG186″][vc_tta_accordion][vc_tta_section title=”Program” tab_id=”1713882797891-aa793d05-7d9c”][vc_column_text]    	\n        View Programme         \n        [/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/radiation-oncology-contouring-and-planning-pre-conference-workshop/
LOCATION:Grand Royal Swiss Hotel\, Kisumu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241031T193000
DTEND;TZID=Africa/Nairobi:20241031T203000
DTSTAMP:20260424T040811
CREATED:20241011T163557Z
LAST-MODIFIED:20250622T144124Z
UID:10032-1730403000-1730406600@kesho-kenya.org
SUMMARY:HER2 Breast Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/her2-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241024T193000
DTEND;TZID=Africa/Nairobi:20241024T203000
DTSTAMP:20260424T040811
CREATED:20241011T163444Z
LAST-MODIFIED:20250622T144124Z
UID:10030-1729798200-1729801800@kesho-kenya.org
SUMMARY:Tripple Negative Breast Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/tripple-negative-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241017T193000
DTEND;TZID=Africa/Nairobi:20241017T203000
DTSTAMP:20260424T040811
CREATED:20241011T163154Z
LAST-MODIFIED:20250622T144124Z
UID:10028-1729193400-1729197000@kesho-kenya.org
SUMMARY:Breast Cancer in Young Women
DESCRIPTION:
URL:https://kesho-kenya.org/event/breast-cancer-in-young-women/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241010T193000
DTEND;TZID=Africa/Nairobi:20241010T203000
DTSTAMP:20260424T040811
CREATED:20241011T162615Z
LAST-MODIFIED:20250622T144125Z
UID:10024-1728588600-1728592200@kesho-kenya.org
SUMMARY:Hormone Receptor
DESCRIPTION:
URL:https://kesho-kenya.org/event/hormone-receptor-copy/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241010T190000
DTEND;TZID=Africa/Nairobi:20241010T203000
DTSTAMP:20260424T040811
CREATED:20241011T162538Z
LAST-MODIFIED:20250622T144124Z
UID:10022-1728586800-1728592200@kesho-kenya.org
SUMMARY:Positive Breast Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/positive-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20241003T073000
DTEND;TZID=Africa/Nairobi:20241003T203000
DTSTAMP:20260424T040811
CREATED:20241011T161126Z
LAST-MODIFIED:20250622T144125Z
UID:10020-1727940600-1727987400@kesho-kenya.org
SUMMARY:Cervical Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/cervical-cancer-2/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240926T193000
DTEND;TZID=Africa/Nairobi:20240926T203000
DTSTAMP:20260424T040811
CREATED:20240704T122734Z
LAST-MODIFIED:20250622T144126Z
UID:9877-1727379000-1727382600@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/prostate-cancer-7/
CATEGORIES:Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240926T193000
DTEND;TZID=Africa/Nairobi:20240926T203000
DTSTAMP:20260424T040811
CREATED:20240704T140045Z
LAST-MODIFIED:20250622T144125Z
UID:9888-1727379000-1727382600@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/prostate-cancer-8/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240919T193000
DTEND;TZID=Africa/Nairobi:20240919T203000
DTSTAMP:20260424T040811
CREATED:20240704T122542Z
LAST-MODIFIED:20250622T144126Z
UID:9875-1726774200-1726777800@kesho-kenya.org
SUMMARY:Word CML Day
DESCRIPTION:
URL:https://kesho-kenya.org/event/word-cml-day/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240912T193000
DTEND;TZID=Africa/Nairobi:20240912T203000
DTSTAMP:20260424T040811
CREATED:20240704T122332Z
LAST-MODIFIED:20250622T144126Z
UID:9872-1726169400-1726173000@kesho-kenya.org
SUMMARY:Endrometrial Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/endrometrial-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240905T193000
DTEND;TZID=Africa/Nairobi:20240905T203000
DTSTAMP:20260424T040811
CREATED:20240704T122050Z
LAST-MODIFIED:20250622T144126Z
UID:9870-1725564600-1725568200@kesho-kenya.org
SUMMARY:Childhood Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/childhood-cancer-3/
CATEGORIES:Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240829T190000
DTEND;TZID=Africa/Nairobi:20240829T203000
DTSTAMP:20260424T040811
CREATED:20240829T080756Z
LAST-MODIFIED:20250622T144125Z
UID:9931-1724958000-1724963400@kesho-kenya.org
SUMMARY:Management of Cervical Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Khadija Warfa\nKhadija Warfa is a Gynecologic Oncologist\, who completed her gynaecological oncology fellowship at the University of Calgary\, Canada. \nCurrently Dr. Warfa is an Assistant Professor in the Department of Obstetrics and Gynecology at The Aga Khan University Hospital\, where she had done her Obstetrics and Gynecology residency training. She is involved in the training and supervision of postgraduate students. \nDr. Warfa is a member of the African Cancer Coalition and European society of gynecologic oncology (ESGO). She is involved in the Harmonized NCCN guidelines and is a technical advisor to the Kenya National cancer treatment protocols with the objective to reduce mortality related to Gynecologic Cancers in Kenya. \nDr Sheynaz Bassa\nSheynaz Bassa is the Head of Radiation Oncology at Steve Biko Academic hospital\, University of Pretoria. Her research interest is on genitourinary cancers\, with a focus on HIV related cervix cancers. \nDr Jonathan Wawire\nJonathan Wawire is an anatomic pathologist and Assistant Professor at Aga Khan University Hospital\, Nairobi\, with a strong background in Gynecologic Pathology. \nHe has held various leadership roles within the Kenya Association of Clinical Pathologists\, contributing to the advancement of pathology education and practice in the region. \nDr. Wawire is also a dedicated researcher with numerous peer-reviewed publications\, and he has received the International Society of Gynecological Pathologists Young Member Award for his work on endometrial carcinoma in Kenya. His commitment to fostering collaboration through case reviews and conferences underscores his dedication to improving pathology services and training. \nDr Omar Abdihamid (Moderator)\nOmar Abdihamid is a Consultant Oncologist working in Nairobi and Garissa Cancer Center. He holds a master’s degree in Clinical Oncology from Central South University in China. \nHis main research and clinical interests include improving care in cancers of the head and neck\, Esophagus and Genitourinary cancers. \nDr. Omar is passionate about global oncology\, cancer care access\, and equity in low- and middle-income countries\, and advocates for culturally based cancer care\, affordability\, patient education\, digital health\, and access to treatment. \nHe is also a published cancer researcher\, editor\, and reviewer in medical journals.\nHe is a fellow of \n\n2023 American Society of Clinical Oncology (ASCO) International Development Education Award (IDEA)\nFellow of the African Cancer Leadership Institute (ACLI)\,\nThe winner of the ASCO VOICES 2022 Award– for highlighting the state of cancer care in Kenya.\n\n[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_btn title=”REGISTRATION” color=”danger” link=”url:https%3A%2F%2Fus02web.zoom.us%2Fwebinar%2Fregister%2FWN_Fqjdhrm_Qh2ooxOMHvDvyg”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/management-of-cervical-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/08/Management-of-Cervical-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240820T193000
DTEND;TZID=Africa/Nairobi:20240825T203000
DTSTAMP:20260424T040811
CREATED:20240704T123725Z
LAST-MODIFIED:20250622T144125Z
UID:9884-1724182200-1724617800@kesho-kenya.org
SUMMARY:Hepatobiliary Conference
DESCRIPTION:
URL:https://kesho-kenya.org/event/hepatobiliary-conference/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240815T190000
DTEND;TZID=Africa/Nairobi:20240815T203000
DTSTAMP:20260424T040811
CREATED:20240704T123012Z
LAST-MODIFIED:20250622T144125Z
UID:9881-1723748400-1723753800@kesho-kenya.org
SUMMARY:Nutrition for Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nMs Joyce Awuor\nB.A. (Sociology & Psychology)\, BSc. (Human Nutrition & Dietetics)\, Pg. (Pediatric Nutrition)\nJoyce Awuor Joyce is a Consultant Dietitian and has recently been awarded the prestigious AfriGlo Women’s Choice Award for The Nutritionist of the Year 2024. \nMs. Joyce previously worked at The Aga Khan University Hospital and Coptic Hospital and currently serves as a Consultant Dietitian at Waridi Children’s Medical Centre and Mirazi Healthcare. Additionally\, Ms. Joyce holds a lecturer position (Dep. of Human Nutrition & Dietetics) at the Kenya Medical Training College (KMTC) in Karen Campus. She is also the CEO and Founder of Diet Select\, an organization dedicated to providing expert dietary and nutritional guidance. Diet Select can be accessed across all social media platforms\, where Ms. Joyce and her team share videos and insights on various diet and nutrition topics. \nHer expertise has been widely recognized in various health segments in mainstream media\, where she has been featured in numerous health interviews and as a speaker at several scientific conferences\, where she contributes to advancing knowledge in the field of dietetics and nutrition. \nWith a strong passion for disseminating scientific information on healthy eating\, Ms. Joyce is committed to enhancing public awareness and promoting healthy food choices and practices for overall well-being. \nDr Gladwell Kiarie\nGladwell Kiarie graduated with MBChB (Bachelor of Medicine and Bachelor of Surgery) degrees from The University of Nairobi and went head to receive her post-graduate degree in Internal Medicine from the same institution. After receiving her undergraduate degrees\, she did her internship at the Kenyatta National Hospital before proceeding to pursue her fellowship in Medical Oncology in London\, England. \nAfter sub-specialization in Medical Oncology\, she returned to Kenya where she was one of the founding members of the Oncology Unit at the Aga Khan University Hospital and was also part of the team that set up the first Kenyatta National Hospital Tumor Board in 2007 that involved multiple personnel from surgical and medical departments. \nShe then joined the University of Nairobi in the Clinical Medicine Department as a Senior Lecturer. Soon afterwards\, she enrolled in a PhD program with the Bart’s Cancer Institute under the supervision of Professor John Gribben. She recently received Fellowship to the Royal College of Physicians of Edinburgh (FRCPE). \nDr Kiarie currently runs a private practice at The Nairobi Hospital and also reviews patients at other leading hospitals in Nairobi and Nakuru including The Aga Khan University Hospital\, MP Shah Hospital\, and Avenue Hospital. She also serves in the Kenya Medical Practitioners and Dentists Board since her appointment in 2015 to the Regulatory Department of the Board. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO) where she also served as the treasurer in 2004 and is also a full member of the American Society of Clinical Oncology (ASCO) as well as European Society for Medical Oncology (ESMO). \nShe continues to be an advocate for early diagnosis of cancer and is greatly involved in programs that focus on providing easy access to basic screening services to the under privileged including setting up oncology services at the county level. In recognition of this\, she won the Union for International Cancer Control (UICC) in 2014 for screening in poor settings. \nMr Josphat Nthae Nzusyo (Moderator)\nJosphat Nthae Nzusyo is a goal-oriented\, assertive\, and dedicated healthcare professional with a Bachelor of Science in Nursing from the University of Eastern Africa\, Baraton. He is a SIOP-trained Pediatric Oncology Nursing Trainer (2023 Tanzania Cohort)\, trained in Childhood palliative care by KEHPCA and a passionate advocate for childhood cancer patients. \nCurrently serving as a nurse team leader and researcher in the Pediatric Hematology Oncology unit at Kenyatta National Hospital\, He is on a mission to save lives and provide holistic care to young cancer warriors. He actively engages in improving pediatric oncology nursing care\, education\, and training. His dedication to continuous learning ensures he remains at the forefront of pediatric oncology\, consistently implementing best practices and innovative care strategies. \nJosphat’s leadership and commitment to excellence have led him to spearhead several quality improvement initiatives aimed at enhancing the quality of care for childhood cancer patients. His work not only focuses on clinical outcomes but also emphasizes the importance of compassionate\, patient-centered care. As a trained professional in childhood palliative care\, he integrates this crucial aspect into his practice\, ensuring comprehensive support for patients and their families throughout their cancer journey. \nIn addition to his clinical and research roles\, He is a respected trainer and mentor\, inspiring fellow healthcare professionals to excel in delivering exceptional care. His involvement in continuous education and training programs helps equip nurses with the skills and knowledge needed to tackle the challenges of pediatric oncology nursing hence improving the lives of childhood cancer patients.[/vc_column_text][vc_video link=”” title=”Webinar Recording”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/nutrition-for-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/Nutrition-and-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240808T190000
DTEND;TZID=Africa/Nairobi:20240808T203000
DTSTAMP:20260424T040811
CREATED:20240704T122842Z
LAST-MODIFIED:20250622T144126Z
UID:9879-1723143600-1723149000@kesho-kenya.org
SUMMARY:Sickle Cell Disease
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Miguel R. Abboud\nMiguel R. Abboud earned his medical degree and then pediatrics training at the American University of Beirut\, Lebanon (1984). He completed his hematology-oncology specialty training at the Memorial Sloan-Kettering Cancer Center and The New York Hospital\, Cornell University Medical Center\, New York\, NY\, USA (1987). He was professor at Medical University of South Carolina until in August 2002\, he became the first Medical Director of the Children’s Cancer Center of Lebanon (CCCL) at the American University of Beirut Medical Center in Lebanon and Professor of Pediatrics at AUB. He established highly visible and successful bone marrow transplant\, limb salvage surgery\, and sickle cell disease programs as well as an acute lymphoblastic leukemia research protocol in collaboration with the Leukemia/Lymphoma Division at St. Jude Children’s Research Hospital in Memphis\, TN\, USA. In February 2011\, he was appointed as Chairman of the Department of Pediatrics and Adolescent Medicine at AUBMC and was offered tenured appointment as Professor of Pediatrics at AUB in July 2018. He was assigned as Scientific Advisor of the SCD Association of America in May 2019. He is also the chair of the Red Cell Biology Scientific Committee of the American Society of Hematology. He is consultant on multiple Sickle Cell Disease multicenter clinical trials protocol development. He has published above 170 publications in peer-reviewed journals. \nDr Abboud has been accorded numerous awards and honors. These include Physician of the Year by the National Committee for Lebanese Children in 2007\, a “Miracle Maker” award from A.H. Robbins in 1995\, and the Mitchell Rubin Research Award in Pediatrics in 1993\, among others. \nDr Doreen Mutua\nDoreen Mutua is a pediatrician whose passion for children with blood disorders and cancer was ignited during her residency training at the University of Nairobi where she noticed that most of these children had dismal outcomes due to late presentation\, lack of appropriate diagnostic and treatment facilities. \nDr. Mutua is a beneficiary of a two year training program conducted as a twinning program between Jimma University (Ethiopia) and ASLAN Project (a USA based Non- Governmental organization) that seeks to build capacity of   low and middle income countries in treating children with blood disorders and cancer. \nShe completed her training in May 2018 and returned back to Kenya to establish hematology/oncology services that include centers of excellence for pediatric cancer care and comprehensive sickle cell care at the Gertrude’s Children’s Hospital. \nShe is passionate about raising awareness on childhood cancer with regard to early detection\, establishing treatment guidelines and improving outcomes of Kenyan children who have cancer. She is also keen on seeing the establishment of comprehensive sickle cell centers in the country which can help reduce the morbidity and mortality of these patients. \nDr Anne Mwirigi\nAnne Mwirigi is an Assistant Professor and Consultant Haematologist working at the Aga Khan University Hospital in Nairobi\, Kenya. She obtained her undergraduate MBChB from the University of Glasgow in 2002. After her house jobs and a medical rotation in Glasgow\, she moved to London in February 2007. \nHer career in Haematology began as a senior house officer at King’s College Hospital\, following which she was accepted on the Guy’s and St Thomas’ NHS Trust Specialist Registrar Rotation in 2009. She obtained her certificate of completion of training in 2014\, and thereafter took on consultant haematologist positions for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals. \nDr Mwirigi has a passion for haematology and always planned to practice haematology in her country of birth\, Kenya. Since moving back in December 2016\, she has engaged with haematopathologists and clinical haematologists in the region\, and is involved collaborative ventures aimed at improving the quality of haematology services in Kenya. She was a key member of the scientific committee which organised the Haematology and Oncology Society of Africa 3rdinaugural conference held in Nairobi in August 2017. \nDr Sarah Muma\nSarah Muma is a Pediatric Hemato – Oncologist at Kenyatta National Hospital. \nShe is a graduate of the University of Nairobi where she received her Bachelor’s degree (MBChB) as well as her Master’s degree in Pediatrics and Child Health. Dr Muma did a fellowship in Pediatric Oncology at Frere Hospital\, Walter Sisulu University in East London\, South Africa. She also holds a Master’s degree in Advanced Oncology from Ulm University in Germany. Her main interest is in developing low-cost\, high impact models of management for children with cancer in low-income settings. \nDr Rohini Radia\nRohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005. \nDuring her haematology training and work as a consultant\, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation\, including 10 years at consultant level at The Russell Centre for Clinical Haematology\, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023\, she returned home and started as BMT Consultant at the The Nairobi West Hospital. She is currently based at the Aga Khan University Hospital. \nHer BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol\, GVHD prophylaxis and post-transplant management of immune suppression\, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia\, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials. \nDr Grace Mbatia\nGrace Mbatia is currently serving as Full-time faculty at the Aga Khan University\, Nairobi providing clinical care to children with blood and cancer disorders as well as supporting paediatric post-graduate medical training for future paediatricians. Her core clinical interests lie in providing care to children with brain and solid tumors whereas her broader interests include supporting medical education\, health-systems research and the optimization of both general paediatric and paediatric blood and cancer care in resource-constrained settings. \nDr Catherine Muendo\nCatherine Muendo is a Paediatric Hematologist and Oncologist who completed her fellowship training at Makerere university in collaboration with Mulago National Referral Hospital\, Baylor college of medicine and Texas cancer children’s hospital. \nShe works as a consultant paediatrician at Kenyatta National Hospital. Dr Muendo received her medical degree (MBChB) and pediatrics and child health degree (MMed) at the University of Nairobi. \nShe is enthusiastic about improving the outcomes of children with blood and cancer disorders in Kenya through novel interventions that are sustainable in a resource limited setting. \nDr Irene Nzamu (Moderator)\nIrene Nzamu is a Pediatric Hematologist Oncologist. She is the Head of the Pediatric Hemato Oncology Unit at the Kenyatta National Hospital. \nDr Nzamu attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi. She did her Fellowship in Pediatric Hematology & Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital. \nShe is passionate about offering evidence based\, affordable care for children with cancer & blood diseases in our resource limited settings.[/vc_column_text][vc_video link=”” title=”Webinar Recording”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/sickle-cell-disease/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/sickle-cell.jpg
END:VEVENT
END:VCALENDAR